loadpatents
Patent applications and USPTO patent grants for Cleland; Jeffrey L..The latest application filed is for "aggregated microparticles".
Patent | Date |
---|---|
Aggregating microparticles for medical therapy Grant 11,331,276 - Yu , et al. May 17, 2 | 2022-05-17 |
Extended release microparticles and suspensions thereof for medical therapy Grant 11,160,870 - Yang , et al. November 2, 2 | 2021-11-02 |
Aggregated Microparticles App 20210275456 - Yang; Ming ;   et al. | 2021-09-09 |
Compounds And Compositions For Ocular Delivery App 20210214374 - Bauman; John G. ;   et al. | 2021-07-15 |
Extended recombinant polypeptides and compositions comprising same Grant 10,961,287 - Schellenberger , et al. March 30, 2 | 2021-03-30 |
Drugs To Treat Ocular Disorders App 20210040111 - Yang; Ming ;   et al. | 2021-02-11 |
Drugs And Compositions For Ocular Delivery App 20200308162 - Cleland; Jeffrey L. ;   et al. | 2020-10-01 |
Extended Release Microparticles And Suspensions Thereof For Medical Therapy App 20200230246 - Yang; Ming ;   et al. | 2020-07-23 |
Drugs And Compositions For The Treatment Of Ocular Disorders App 20200031783 - Yang; Ming ;   et al. | 2020-01-30 |
Aggregating Microparticles For Medical Therapy App 20200000735 - Yu; Yun ;   et al. | 2020-01-02 |
Aggregating Microparticles For Medical Therapy App 20200000734 - Yu; Yun ;   et al. | 2020-01-02 |
Compounds and compositions for the treatment of ocular disorders Grant 10,485,876 - Cleland , et al. Nov | 2019-11-26 |
Aggregating microparticles for medical therapy Grant 10,441,548 - Yu , et al. Oc | 2019-10-15 |
Compounds And Compositions For The Treatment Of Ocular Disorders App 20190060474 - Cleland; Jeffrey L. ;   et al. | 2019-02-28 |
Compounds and compositions for the treatment of ocular disorders Grant 10,159,747 - Cleland , et al. Dec | 2018-12-25 |
Extended Release Microparticles And Suspensions Thereof For Medical Therapy App 20180326078 - Yang; Ming ;   et al. | 2018-11-15 |
Compounds and compositions for the treatment of ocular disorders Grant 10,117,950 - Cleland , et al. November 6, 2 | 2018-11-06 |
Compounds and compositions for the treatment of ocular disorders Grant 10,111,964 - Cleland , et al. October 30, 2 | 2018-10-30 |
Compounds and compositions for the treatment of ocular disorders Grant 10,098,965 - Cleland , et al. October 16, 2 | 2018-10-16 |
Extended Recombinant Polypeptides And Compositions Comprising Same App 20180244736 - Schellenberger; Volker ;   et al. | 2018-08-30 |
Glucose-regulating polypeptides and methods of making and using same Grant 10,000,543 - Schellenberger , et al. June 19, 2 | 2018-06-19 |
Growth Hormone Polypeptides And Methods Of Making And Using Same App 20180161443 - Schellenberger; Volker ;   et al. | 2018-06-14 |
Compounds and compositions for the treatment of ocular disorders Grant 9,956,302 - Cleland , et al. May 1, 2 | 2018-05-01 |
Compounds And Compositions For The Treatment Of Ocular Disorders App 20180104350 - Cleland; Jeffrey L. ;   et al. | 2018-04-19 |
Extended recombinant polypeptides and compositions comprising same Grant 9,926,351 - Schellenberger , et al. March 27, 2 | 2018-03-27 |
Compounds And Compositions For The Treatment Of Ocular Disorders App 20180064823 - Cleland; Jeffrey L. ;   et al. | 2018-03-08 |
Treatment With Human Growth Hormone Analogues App 20180051063 - Cleland; Jeffrey L. ;   et al. | 2018-02-22 |
Compounds And Compositions For The Treatment Of Ocular Disorders App 20180036416 - Cleland; Jeffrey L. ;   et al. | 2018-02-08 |
Compounds And Compositions For The Treatment Of Ocular Disorders App 20180028673 - Cleland; Jeffrey L. ;   et al. | 2018-02-01 |
Growth hormone polypeptides and methods of making and using same Grant 9,849,188 - Schellenberger , et al. December 26, 2 | 2017-12-26 |
Compounds and compositions for the treatment of ocular disorders Grant 9,808,531 - Cleland , et al. November 7, 2 | 2017-11-07 |
Glucose-regulating Polypeptides And Methods Of Making And Using Same App 20170158748 - Schellenberger; Volker ;   et al. | 2017-06-08 |
Aggregating Microparticles For Medical Therapy App 20170135960 - Yu; Yun ;   et al. | 2017-05-18 |
Growth Hormone Polypeptides And Methods Of Making And Using Same App 20170095567 - Schellenberger; Volker ;   et al. | 2017-04-06 |
Compounds And Compositions for the Treatment of Ocular Disorders App 20170080092 - Cleland; Jeffrey L. ;   et al. | 2017-03-23 |
Extended Recombinant Polypeptides And Compositions Comprising Same App 20170037088 - Schellenberger; Volker ;   et al. | 2017-02-09 |
Glucose-regulating polypeptides and methods of making and using same Grant 9,540,430 - Schellenberger , et al. January 10, 2 | 2017-01-10 |
Extended recombinant polypeptides and compositions comprising same Grant 9,371,369 - Schellenberger , et al. June 21, 2 | 2016-06-21 |
Treatment Of Pediatric Growth Hormone Deficiency With Human Growth Hormone Analogues App 20160158321 - CLELAND; Jeffrey L. ;   et al. | 2016-06-09 |
Protein formulation Grant 9,283,273 - Andya , et al. March 15, 2 | 2016-03-15 |
Growth hormone polypeptides and methods of making and using same Grant 9,168,312 - Schellenberger , et al. October 27, 2 | 2015-10-27 |
Glucose-regulating Polypeptides And Methods Of Making And Using Same App 20150274800 - Schellenberger; Volker ;   et al. | 2015-10-01 |
Glucose-regulating polypeptides and methods of making and using same Grant 8,957,021 - Schellenberger , et al. February 17, 2 | 2015-02-17 |
Growth Hormone Polypeptides And Methods Of Making And Using Same App 20140371136 - Schellenberger; Volker ;   et al. | 2014-12-18 |
Recombinant production of vascular endothelial growth factor Grant 8,906,648 - Butler , et al. December 9, 2 | 2014-12-09 |
Extended Recombinant Polypeptides And Compositions Comprising Same App 20140301974 - Schellenberger; Volker ;   et al. | 2014-10-09 |
Treatment With Human Growth Hormone Analogues App 20140162949 - Cleland; Jeffrey L. ;   et al. | 2014-06-12 |
Growth hormone polypeptides and methods of making and using same Grant 8,703,717 - Schellenberger , et al. April 22, 2 | 2014-04-22 |
Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same Grant 8,680,050 - Schellenberger , et al. March 25, 2 | 2014-03-25 |
Extended recombinant polypeptides and compositions comprising same Grant 8,673,860 - Schellenberger , et al. March 18, 2 | 2014-03-18 |
Protein Formulation App 20130224185 - Andya; James ;   et al. | 2013-08-29 |
Recombinant Production of Heparin Binding Proteins App 20130217867 - Butler; Michelle D. ;   et al. | 2013-08-22 |
Bioerodible polymers for injection Grant 8,501,216 - Cleland , et al. August 6, 2 | 2013-08-06 |
High Pressure Treatment of Aggregated Interferons App 20130058895 - Cleland; Jeffrey L. ;   et al. | 2013-03-07 |
High pressure treatment of aggregated interferons Grant 8,273,561 - Cleland , et al. September 25, 2 | 2012-09-25 |
Bifunctional Polypeptide Compositions And Methods For Treatment Of Metabolic And Cardiovascular Diseases App 20110312881 - Silverman; Joshua ;   et al. | 2011-12-22 |
Sustained release formulation Grant 8,067,020 - Okumu , et al. November 29, 2 | 2011-11-29 |
Protein Formulation App 20110236383 - Andya; James ;   et al. | 2011-09-29 |
Erodible Polymers For Injection App 20110152190 - CLELAND; Jeffrey L. ;   et al. | 2011-06-23 |
Injection Vehicle For Polymer-based Formulations App 20100330184 - Cleland; Jeffrey L. ;   et al. | 2010-12-30 |
Erodible polymers for injection Grant 7,824,700 - Cleland , et al. November 2, 2 | 2010-11-02 |
Recombinant Production of Heparin Binding Proteins App 20100261888 - Butler; Michelle D. ;   et al. | 2010-10-14 |
Extended Recombinant Polypeptides And Compositions Comprising Same App 20100239554 - Schellenberger; Volker ;   et al. | 2010-09-23 |
Protein Formulation App 20100158899 - Andya; James ;   et al. | 2010-06-24 |
Protein formulation Grant 7,682,609 - Andya , et al. March 23, 2 | 2010-03-23 |
Injection vehicle for polymer-based formulations Grant 7,651,703 - Cleland , et al. January 26, 2 | 2010-01-26 |
Injection vehicle for polymer-based formulations Grant 7,582,311 - Cleland , et al. September 1, 2 | 2009-09-01 |
High pressure treatment of aggregated interferons App 20090208453 - Cleland; Jeffrey L. ;   et al. | 2009-08-20 |
Prevention and Treatment of Gastrointestinal and Bladder Disorders Associated with Chemotherapy or Radiation Therapy Using Active Vitamin D Compounds App 20090163453 - Curd; John G. ;   et al. | 2009-06-25 |
Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin D compounds or mimics thereof App 20090069276 - Curd; John G. ;   et al. | 2009-03-12 |
Sustained Release Formulation App 20080090754 - Okumu; Franklin ;   et al. | 2008-04-17 |
Sustained release formulation Grant 7,318,931 - Okumu , et al. January 15, 2 | 2008-01-15 |
Treatment of hyperproliferative diseases with anthraquinones App 20070117784 - Cleland; Jeffrey L. ;   et al. | 2007-05-24 |
Injection Vehicle For Polymer-based Formulations App 20070098736 - Cleland; Jeffrey L. ;   et al. | 2007-05-03 |
Controlled release microencapsulated NGF formulation Grant 7,163,701 - Cleland , et al. January 16, 2 | 2007-01-16 |
Protein formulation App 20060275306 - Andya; James ;   et al. | 2006-12-07 |
Pharmaceutical compositions comprising active vitamin D compounds App 20060189586 - Cleland; Jeffrey L. | 2006-08-24 |
Treatment of immune-mediated disorders with active vitamin D compounds alone or in combination with other therapeutic agents App 20060178351 - Curd; John G. ;   et al. | 2006-08-10 |
Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatments App 20060177374 - Curd; John G. ;   et al. | 2006-08-10 |
Treatment of lung cancer with active vitamin D compounds in combination with other treatments App 20060172014 - Curd; John G. ;   et al. | 2006-08-03 |
Protein formulation Grant 7,060,268 - Andya , et al. June 13, 2 | 2006-06-13 |
Compositions for microencapsulation of antigens for use as vaccines Grant 6,913,767 - Cleland , et al. July 5, 2 | 2005-07-05 |
Protein formulation Grant 6,821,515 - Cleland , et al. November 23, 2 | 2004-11-23 |
Targeted therapeutic lipid constructs App 20040067196 - Brunke, Karen J. ;   et al. | 2004-04-08 |
Protein formulation Grant 6,685,940 - Andya , et al. February 3, 2 | 2004-02-03 |
Controlled release microencapsulated NGF formulation Grant 6,663,899 - Cleland , et al. December 16, 2 | 2003-12-16 |
Protein formulation App 20030202972 - Andya, James ;   et al. | 2003-10-30 |
Controlled release microencapsulated NGF formulation App 20030203040 - Cleland, Jeffrey L. ;   et al. | 2003-10-30 |
Sustained release formulation App 20030045454 - Okumu, Franklin ;   et al. | 2003-03-06 |
Erodible polymers for injection App 20020173552 - Cleland, Jeffrey L. ;   et al. | 2002-11-21 |
Controlled Release Microencapsulated Ngf Formulation App 20020004481 - CLELAND, JEFFREY L. ;   et al. | 2002-01-10 |
Protein formulation App 20010014326 - Andya, James ;   et al. | 2001-08-16 |
Protein formulation Grant 6,267,958 - Andya , et al. July 31, 2 | 2001-07-31 |
Controlled release microencapsulated NGF formulation Grant 6,113,947 - Cleland , et al. September 5, 2 | 2000-09-05 |
Method for drying microspheres Grant 6,080,429 - Cleland , et al. June 27, 2 | 2000-06-27 |
Excipient stabilization of polypeptides treated with organic solvents Grant 5,804,557 - Cleland , et al. September 8, 1 | 1998-09-08 |
Excipient stabilization of polypeptides treated with organic solvents Grant 5,753,219 - Cleland , et al. May 19, 1 | 1998-05-19 |
Methods and compositions for microencapsulation of adjuvants Grant 5,643,605 - Cleland , et al. July 1, 1 | 1997-07-01 |
Excipient stabilization of polypeptides treated with organic solvents Grant 5,589,167 - Cleland , et al. December 31, 1 | 1996-12-31 |
SEC | 0001601948 | Cleland Jeffrey L |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.